Imperial College London

MrMikaelSodergren

Faculty of MedicineDepartment of Surgery & Cancer

Clinical Senior Lecturer in Hepatopancreatobiliary Surgery
 
 
 
//

Contact

 

m.sodergren

 
 
//

Location

 

BN2/13Block B Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Sarker:2019,
author = {Sarker, D and Plummer, R and Basu, B and Meyer, T and Ma, Y-T and Evans, J and Palmer, DH and Huang, K-W and Chee, E and Spalding, D and Sodergren, M and Habib, N},
pages = {168--+},
publisher = {OXFORD UNIV PRESS},
title = {First-in-human, first-in-class phase I study of MTL-CEBPA, a RNA oligonucleotide targeting the myeloid cell master regulator C/EBP-α, in patients with advanced hepatocellular cancer (HCC)},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295501272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Sarker,D
AU - Plummer,R
AU - Basu,B
AU - Meyer,T
AU - Ma,Y-T
AU - Evans,J
AU - Palmer,DH
AU - Huang,K-W
AU - Chee,E
AU - Spalding,D
AU - Sodergren,M
AU - Habib,N
EP - 168
PB - OXFORD UNIV PRESS
PY - 2019///
SN - 0923-7534
SP - 168
TI - First-in-human, first-in-class phase I study of MTL-CEBPA, a RNA oligonucleotide targeting the myeloid cell master regulator C/EBP-α, in patients with advanced hepatocellular cancer (HCC)
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295501272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -